Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection
Saved in:
Main Authors: | Seung In Seo, Woon Geon Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean College of Helicobacter and Upper Gastrointestinal Research
2022-09-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2022-0025.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
by: Sung Eun Kim, et al.
Published: (2021-03-01) -
Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
by: Seon Woo Oh, et al.
Published: (2025-03-01) -
Optimal First-line Eradication Regimens for Helicobacter pylori Infection in Patients with Clarithromycin Resistance: A Pilot Study
by: Min Woo Seo, et al.
Published: (2018-12-01) -
Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
by: Qiyunna He, et al.
Published: (2024-05-01) -
Clarithromycin Resistance Rates of Helicobacter pylori Infected Gastric Biopsies in Korea
by: Moo-Sang CHONG, et al.
Published: (2025-06-01)